Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
about
Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factorMyocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failureDual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosisExamining the association between salivary cortisol levels and subclinical measures of atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation.Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyPharmacological Treatment of Heart Failure with Preserved Ejection FractionSex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity.Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".Cortisol responses to mental stress and the progression of coronary artery calcification in healthy men and women.Urinary cortisol and six-year risk of all-cause and cardiovascular mortality.Glucocorticoids Induce Cardiac Fibrosis via Mineralocorticoid Receptor in Oxidative Stress: Contribution of Elongation Factor Eleven-Nineteen Lysine-Rich Leukemia (ELL).Aldosterone and mortality in hemodialysis patients: role of volume overload.Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression.Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.Regulation of circulating progenitor cells in left ventricular dysfunction.Psychobiology of depression/distress in congestive heart failureExamination of the potential association of stress with morbidity and mortality outcomes in patient with heart failure.Corticosteroids Mediate Heart Failure-Induced Depression through Reduced σ1-Receptor Expression.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.Does depression impact cognitive impairment in patients with heart failure?Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.Sleep Disruption is Associated with Increased Ventricular Ectopy and Cardiac Arrest in Hospitalized Adults.Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction.Long term outcome of Aldosteronism after target treatments.Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.New and emerging biomarkers of heart failure.Understanding how we age: insights into inflammagingHypoglycaemia increases aldosterone in a dose-dependent fashion.Targeting the aldosterone pathway in cardiovascular disease.Mineralocorticoid receptor antagonists for heart failure.Prevention of heart failure in the elderly: when, where and how to begin?Aldosterone in heart disease.Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.Cardiac myocyte-fibroblast interactions and the coronary vasculature.Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.How are depression and type D personality associated with outcomes in chronic heart failure patients?
P2860
Q24311808-66FB47C4-FF0A-4C90-8AF1-4BBBCDF85733Q24648449-0020A9AF-1A64-45E8-9604-097E28BA5CACQ28580617-5988A921-3555-4E81-B448-86B75BB0750FQ33607862-E0C62D7D-4951-4A0F-8E09-4258D872DCB4Q33856656-DB69075E-3126-4443-9FF2-2332FC8BA59BQ33871492-D1604338-253B-4DB8-85A8-A2CDBCF1E7A5Q33885952-DDC1425E-A14D-4F87-A443-6A1462C87527Q34014004-99979295-C105-4B38-8CA9-FB7A47F4E19BQ34121798-0473A601-7B84-4593-A51A-AAD2F523E947Q34157296-B0E7AF5A-3EEC-4591-B121-BB55E4D65459Q34262406-83A4C096-4ED1-4ADD-8554-3A7FBA1C3059Q34403980-381F177D-A6F9-4645-BA7F-2D5E22727084Q34612156-06FA533A-B005-4D60-8F7E-350F5023FC58Q34726918-DC7BB140-E492-40C4-BB7C-8E90ECD220C9Q34784461-B269124E-EC53-4DFE-9932-0BFBFA80ADB2Q34981416-F3AA9DB7-A024-4ED5-964C-FD893193BE8CQ34989233-85908F6C-25CA-4F57-A9F4-5D0C226FAC48Q35293910-B5E4EE33-D17A-416D-B2DE-9B5482195B39Q35911866-DEEA83FD-510A-4107-8462-E8ECC3E44227Q36163630-BF74CFA6-57DA-4622-8728-91FFA7575044Q36167458-F74A88B5-9E74-43D3-81C8-87BEC866CA5AQ36167914-BAA65757-34AB-4386-9667-F37BE951670DQ36626365-44434E08-C2A2-4E65-954A-CF2B491EA9B2Q36686531-07AA33ED-F46D-43FA-B478-185C51B74D12Q36800757-5354C93C-CE30-43AE-8A88-307BF925FD66Q36866650-F7E0DFD6-B976-4F86-98D7-588E4A6F10D0Q37227936-6FF0E314-B4E4-4BAF-87EB-5CD912EBA8D6Q37407146-7AB2C831-424B-4A1F-8394-B7E21304FC85Q37419451-D007AF71-3AE9-4B07-8BF0-607317940F9AQ37514230-F06A932C-1BA7-4450-9DAB-230712BD5702Q37581232-AF6B294F-E540-469C-840D-2B1F4C6600A9Q37643031-5A6EAEE4-ED46-49AF-8EE3-0A6DACFBC661Q37951665-070F67B5-BFF0-45B2-BE71-48828EA938D8Q37955919-A760C0D6-4C4E-471B-BA6E-24ADC94C02E0Q37978190-E687E72B-7CD5-4453-AEDC-F7152FB8CD9EQ37981980-3A9ECE67-CC91-454C-80C6-C517C5C618DDQ38005732-87493ED3-FDAA-4ADE-A839-054C09290BBDQ38044304-417F71AC-470A-4143-9BF5-2C20542EEA17Q38072297-991F3E90-8214-4106-896F-60387C4B8BF3Q38105488-2BDE9698-7501-4D5F-AE80-3873C7B9912A
P2860
Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Complementary and incremental ...... rone in chronic heart failure.
@en
Complementary and incremental ...... rone in chronic heart failure.
@nl
type
label
Complementary and incremental ...... rone in chronic heart failure.
@en
Complementary and incremental ...... rone in chronic heart failure.
@nl
prefLabel
Complementary and incremental ...... rone in chronic heart failure.
@en
Complementary and incremental ...... rone in chronic heart failure.
@nl
P2093
P1433
P1476
Complementary and incremental ...... rone in chronic heart failure.
@en
P2093
Bruno Allolio
Christiane E Angermann
Dirk Weismann
Georg Ertl
Gülmisal Güder
Johann Bauersachs
Stefan Frantz
Stefan Störk
P304
P356
10.1161/CIRCULATIONAHA.106.653964
P407
P577
2007-03-19T00:00:00Z